Stock MANKIND MANKIND PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Mankind Pharma Limited

Equities

MANKIND

INE634S01028

Delayed NSE India S.E.
Other stock markets
 02:50:57 2024-05-10 am EDT 		5-day change 1st Jan Change
2,227 INR +2.57% Intraday chart for Mankind Pharma Limited -3.57% +12.60%
May. 03 KKR, Novo Nordisk, Others Reportedly Bid for Healthium Buy CI
Apr. 26 Mankind Pharma Limited Receives Order from Office of Commissioner of Central Tax, Central Excise and Service Tax, Secunderabad GST Commissionerate GST Bhawan, Hyderabad CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Mankind Pharma Limited Receives Order from Office of the Assistant Commissioner of Central Tax, Ballygunge Division Kolkata
CI
KKR, Novo Nordisk, Others Reportedly Bid for Healthium Buy
CI
Mankind Pharma Limited Receives Order from Office of Commissioner of Central Tax, Central Excise and Service Tax, Secunderabad GST Commissionerate GST Bhawan, Hyderabad
CI
CARE Gives AA+ Rating to Mankind Pharma's Long-term Bank Financing; Outlook Stable
MT
Mankind Pharma to Sell its Over the Counter Business on Slump Sale Basis
CI
Mankind Pharma to Sell OTC Business to Wholly-Owned Subsidiary
MT
Mankind Pharma to Form New Subsidiary for Consumer Healthcare Products
MT
Mankind Pharma Limited Announces Incorporation of Wholly Owned Subsidiary Mankind Consumer Products Private Limited
CI
Mankind Reportedly Joins Race for Healthium Medtech
CI
AstraZeneca, Mankind Pharma Tie Up for Exclusive Distribution of Asthma Drug Symbicort in India
MT
Astrazeneca Pharma India Ltd and Mankind Pharma Partner to Accelerate Access to Asthma Medicine for Patients in India
CI
India's Jubilant Pharmova posts quarterly profit
RE
Transcript : Mankind Pharma Limited, Q3 2024 Earnings Call, Feb 02, 2024
Mankind Pharma Posts Gains in Fiscal Q3 Consolidated Net Profit; Shares Rise 3%
MT
India's Mankind Pharma beats Q3 profit estimates on strong demand
RE
Mankind Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
India's IPO momentum seen growing on prospects of political stability
RE
BatX Energies Pvt. Ltd. announced that it has received INR 410 million in funding from Zephyr Management, L.P., LetsVenture Online Pte. Ltd., JITO Angel Network, Mankind Pharma Limited, Excel Industries Limited, Blu-Smart Mobility Pvt Ltd and other investors
CI
Mankind Pharma Limited(NSEI:MANKIND) added to FTSE All-World Index
CI
Mankind Pharma Hikes Stake in UK-Based Biopharma Company
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MANKIND Stock
  4. News Mankind Pharma Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW